227 related articles for article (PubMed ID: 38816889)
1. Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods.
Merle JL; Zapata JP; Quieroz A; Zamantakis A; Sanuade O; Mustanski B; Smith JD
Addict Sci Clin Pract; 2024 May; 19(1):46. PubMed ID: 38816889
[TBL] [Abstract][Full Text] [Related]
2. Improving Delivery and Use of HIV Pre-Exposure Prophylaxis in the US: A Systematic Review of Implementation Strategies and Adjunctive Interventions.
Merle JL; Benbow N; Li DH; Zapata JP; Queiroz A; Zamantakis A; McKay V; Keiser B; Villamar JA; Mustanski B; Smith JD
AIDS Behav; 2024 Jul; 28(7):2321-2339. PubMed ID: 38564136
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
Li DH; Benbow N; Keiser B; Mongrella M; Ortiz K; Villamar J; Gallo C; Deskins JS; Xavier Hall CD; Miller C; Mustanski B; Smith JD
J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S235-S246. PubMed ID: 35703776
[TBL] [Abstract][Full Text] [Related]
4. Evidence and implication of interventions across various socioecological levels to address pre-exposure prophylaxis uptake and adherence among men who have sex with men in the United States: a systematic review.
Wang Y; Mitchell JW; Zhang C; Liu Y
AIDS Res Ther; 2022 Jun; 19(1):28. PubMed ID: 35754038
[TBL] [Abstract][Full Text] [Related]
5. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
[TBL] [Abstract][Full Text] [Related]
6. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States.
Keddem S; Thatipelli S; Caceres O; Roder N; Momplaisir F; Cronholm P
J Acquir Immune Defic Syndr; 2024 Apr; 95(4):370-376. PubMed ID: 38133586
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
[TBL] [Abstract][Full Text] [Related]
9. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
11. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.
Shrestha R; Altice FL; Sibilio B; Ssenyonjo J; Copenhaver MM
Contemp Clin Trials; 2019 Jul; 82():77-84. PubMed ID: 31229618
[TBL] [Abstract][Full Text] [Related]
13. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
[TBL] [Abstract][Full Text] [Related]
14. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
[TBL] [Abstract][Full Text] [Related]
15. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.
Glick JL; Zhang L; Rosen JG; Yaroshevich K; Atiba B; Pelaez D; Park JN
JMIR Form Res; 2023 Apr; 7():e42418. PubMed ID: 37052977
[TBL] [Abstract][Full Text] [Related]
16. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.
Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Gaston Hawkins LA; Hansen NB; Kershaw TS; Underhill K; Betancourt JR; Dovidio JF
PLoS One; 2016; 11(6):e0157324. PubMed ID: 27304883
[TBL] [Abstract][Full Text] [Related]
17. The Past, Present, and Future of PrEP implementation Among People Who Use Drugs.
Biello KB; Mimiaga MJ; Valente PK; Saxena N; Bazzi AR
Curr HIV/AIDS Rep; 2021 Aug; 18(4):328-338. PubMed ID: 33907971
[TBL] [Abstract][Full Text] [Related]
18. EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP).
Kaul CM; Moore BE; Kaplan-Lewis E; Casey E; Pitts RA; Pagan Pirallo P; Lim S; Kapadia F; Cohen GM; Khan M; Mgbako O
PLoS One; 2023; 18(9):e0291657. PubMed ID: 37725628
[TBL] [Abstract][Full Text] [Related]
19. HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.
Zhang C; McMahon J; Fiscella K; Przybyla S; Braksmajer A; LeBlanc N; Liu Y
AIDS Patient Care STDS; 2019 Dec; 33(12):507-527. PubMed ID: 31821044
[TBL] [Abstract][Full Text] [Related]
20. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
Mayer KH; Agwu A; Malebranche D
Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
